Solution Group’s subsidiary establishes partnership with CanSino to distribute coronavirus vaccine in Malaysia

Kuala Lumpur, 28 September 2020 – Solution Group Berhad’s subsidiary Solution Biologics Sdn. Bhd. (“SOLBIO”) has forged a partnership with CanSino Biologics Inc. (“CanSinoBIO”) to market and distribute in Malaysia CanSinoBIO’s Recombinant Novel Coronavirus Vaccine. Solution Group board of directors said the vaccine called Adenovirus Type 5 Vector (Ad5-nCoV) will be registered after the completion of …

Solution Group’s subsidiary establishes partnership with CanSino to distribute coronavirus vaccine in Malaysia Read More »